Published in Expert Rev Vaccines on February 01, 2013
Infections and cancer: debate about using vaccines as a cancer control tool. Infect Agent Cancer (2013) 0.78
Nanocarrier-based immunotherapy in cancer management and research. Immunotargets Ther (2014) 0.76
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics (2013) 1.24
Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol (2004) 1.13
Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS One (2013) 1.06
Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies. Oncology (2015) 1.03
Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol (2006) 1.02
Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med (2012) 0.99
Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int J Cancer (2008) 0.99
Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation. J Transl Med (2005) 0.98
Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review. Gynecol Oncol (2012) 0.97
Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference. Lancet Infect Dis (2010) 0.96
Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol (2008) 0.96
Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma. J Transl Med (2009) 0.95
Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer (2007) 0.92
Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Rev Vaccines (2009) 0.91
Antigen-specific vaccines for cancer treatment. Hum Vaccin Immunother (2014) 0.89
Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era. Virology (2010) 0.89
Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. J Clin Virol (2009) 0.88
TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infect Agent Cancer (2011) 0.87
Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? Immunotherapy (2011) 0.87
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts. Planta (2009) 0.84
Human papillomavirus infection in urine samples from male renal transplant patients. J Med Virol (2010) 0.83
VLPs and particle strategies for cancer vaccines. Expert Rev Vaccines (2013) 0.83
Molecular immune signatures of HIV-1 vaccines in human PBMCs. FEBS Lett (2009) 0.83
New adjuvants in evolving vaccine strategies. Expert Opin Biol Ther (2011) 0.83
MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients. Biomarkers (2010) 0.82
TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix. J Transl Med (2014) 0.82
A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women. J Med Virol (2008) 0.82
TP53 codon 72 polymorphism in classic, endemic and epidemic Kaposi's sarcoma in African and Caucasian patients. Oncology (2009) 0.82
Somatic mutations of STK11 gene in human papillomavirus positive and negative penile cancer. Infect Agent Cancer (2013) 0.82
TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda. Cancer Detect Prev (2005) 0.81
Characterization of the human papillomavirus (HPV) integration sites into genital cancers. Pathol Oncol Res (2012) 0.81
Molecular epidemiology of human herpesvirus 8 variants in Kaposi's sarcoma from Iranian patients. Virus Res (2011) 0.81
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model. Cancer Immunol Immunother (2015) 0.80
High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy. APMIS (2011) 0.80
An overview of new biomolecular pathways in pathogen-related cancers. Future Oncol (2015) 0.79
Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model. PLoS One (2013) 0.78
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate. J Transl Med (2013) 0.78
Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines. J Med Virol (2014) 0.78
Cellular prognostic markers in hepatocellular carcinoma. Future Oncol (2015) 0.78
Molecular characterization analysis of the outer protein layer (VP7) from human rotavirus A genotype G1 isolate identified in Iran: implications for vaccine development. New Microbiol (2012) 0.77
Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma. Cancer Lett (2008) 0.77
Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches. Expert Rev Vaccines (2010) 0.77
Report on the AIDS Vaccine 2008 Conference. Hum Vaccin (2009) 0.77
HIV p24 as scaffold for presenting conformational HIV Env antigens. PLoS One (2012) 0.77
Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders. PLoS One (2012) 0.77
Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies. J Transl Med (2011) 0.76
Can HIV p24 be a suitable scaffold for presenting Env antigens? Clin Vaccine Immunol (2011) 0.76
Assessment of Chlamydia trachomatis infection among Eastern European and West African women immigrants in South Italy. Sex Transm Infect (2011) 0.76
Immunogenomics approaches for vaccine evaluation. J Immunotoxicol (2012) 0.76
Quantitative HIV-1 proviral DNA detection: a multicentre analysis. New Microbiol (2010) 0.75
Oncolytic virus therapies. Pharm Pat Anal (2012) 0.75
Pattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particles. J Transl Med (2013) 0.75
Advances in viral oncology research: summary of the 3rd International Meeting. Expert Rev Vaccines (2012) 0.75
Introducing the issue on "differential use of CCR5 versus CXCR4 by HIV-1. Pathogenic, translational and clinical open questions". J Transl Med (2011) 0.75
Unsung hero Robert C. Gallo. Science (2009) 0.75
Development of a stable insect cell line constitutively expressing rotavirus VP2. Virus Res (2012) 0.75
Foreword. Cancer biomarkers. Future Oncol (2015) 0.75
Novel vaccines and adjuvants. Curr HIV Res (2010) 0.75
Systems vaccinology for cancer vaccine development. Expert Rev Vaccines (2014) 0.75